MANNING JOSEPH J 4
4 · ABBOTT LABORATORIES · Filed Sep 9, 2022
Insider Transaction Report
Form 4
MANNING JOSEPH J
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2022-09-08$44.40/sh+23,008$1,021,555→ 76,253 total - Sale
Common shares without par value
2022-09-08$107.00/sh−23,008$2,461,856→ 53,245 total - Exercise/Conversion
Option (right to buy)
2022-09-08−23,008→ 0 totalExercise: $44.40From: 2020-02-17Exp: 2027-02-16→ Common Shares (23,008 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.